• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodies.

作者信息

Cheng Y S, McGowan M H, Kettner C A, Schloss J V, Erickson-Viitanen S, Yin F H

机构信息

Central Research and Development Department, E.I. duPont de Nemours and Co., Wilmington, DE 19880-0328.

出版信息

Gene. 1990 Mar 15;87(2):243-8. doi: 10.1016/0378-1119(90)90308-e.

DOI:10.1016/0378-1119(90)90308-e
PMID:2158928
Abstract

A complete chemical synthesis and assembly of genes for the production of human immunodeficiency virus type-I protease (HIV-PR) and its precursors are described. The T7 expression system was used to produce high levels of active HIV-PR and its precursors in Escherichia coli inclusion bodies. The gene encoding the open reading frames of HIV-PR was expressed in E. coli as a 10-kDa protein, while the genes encoding HIV-PR precursors were expressed as larger proteins, which were partially processed in E. coli to the 10-kDa form. These processing events are autoproteolytic, since a single-base mutation, changing the active-site aspartic acid to glycine, completely abolished the conversion. HIV-PR can be released with 8 M urea from washed cellular inclusion bodies, resulting in a preparation with few bacterial host proteins. After refolding, this preparation contains no nonspecific protease or peptidase activities. The recombinant HIV-PR isolated from inclusion bodies cleaves HIV-PR substrates specifically with a specific activity comparable to column-purified HIV-PR.

摘要

相似文献

1
High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodies.
Gene. 1990 Mar 15;87(2):243-8. doi: 10.1016/0378-1119(90)90308-e.
2
Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli.从大肠杆菌中纯化的1型人类免疫缺陷病毒(HIV - 1)蛋白酶前体和成熟形式的表征及自加工
Proteins. 1989;6(2):139-54. doi: 10.1002/prot.340060205.
3
Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.重组HIV2蛋白酶在体外加工HIV1 Pr53gag和类似的连接肽。
J Biol Chem. 1990 Aug 15;265(23):13890-8.
4
Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.纯化重组HIV-1蛋白酶的底物类似物抑制和活性位点滴定
Biochemistry. 1990 Jan 9;29(1):264-9. doi: 10.1021/bi00453a036.
5
Expression and purification of active form of HIV-1 protease from E.coli.从大肠杆菌中表达并纯化HIV-1蛋白酶的活性形式。
Biochem Mol Biol Int. 1995 Apr;35(4):899-912.
6
High-level expression of self-processed HIV-1 protease in Escherichia coli using a synthetic gene.使用合成基因在大肠杆菌中高效表达自我加工的HIV-1蛋白酶。
Biochem Biophys Res Commun. 1989 Jun 30;161(3):1056-63. doi: 10.1016/0006-291x(89)91350-8.
7
Crystallizable HIV-1 protease derived from expression of the viral pol gene in Escherichia coli.从病毒pol基因在大肠杆菌中的表达获得的可结晶的HIV-1蛋白酶。
Biochem Biophys Res Commun. 1989 Dec 29;165(3):1043-50. doi: 10.1016/0006-291x(89)92707-1.
8
Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.重组猿猴免疫缺陷病毒蛋白酶的纯化及生化特性分析,并与1型人类免疫缺陷病毒蛋白酶进行比较。
Biochemistry. 1991 Aug 27;30(34):8424-34. doi: 10.1021/bi00098a021.
9
Recombinant HIV1 protease secreted by Saccharomyces cerevisiae correctly processes myristylated gag polyprotein.
Proteins. 1989;6(3):324-37. doi: 10.1002/prot.340060315.
10
Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose.
Biochem Biophys Res Commun. 1990 Aug 31;171(1):60-6. doi: 10.1016/0006-291x(90)91356-w.

引用本文的文献

1
Wanted: more monitoring and control during inclusion body processing.需求:在包涵体处理过程中进行更多的监测和控制。
World J Microbiol Biotechnol. 2018 Oct 19;34(11):158. doi: 10.1007/s11274-018-2541-5.
2
Overexpression, Purification and Functional Characterisation of Wild-Type HIV-1 Subtype C Protease and Two Variants Using a Thioredoxin and His-Tag Protein Fusion System.野生型 HIV-1 亚型 C 蛋白酶及其两种变异体的过表达、纯化和功能表征,采用硫氧还蛋白和 His 标签蛋白融合系统。
Protein J. 2018 Aug;37(4):369-379. doi: 10.1007/s10930-018-9779-5.
3
Cloning and Expression of Soluble Recombinant HIV-1 CRF35 Protease-HP Thioredoxin Fusion Protein.
可溶性重组HIV-1 CRF35蛋白酶-HP硫氧还蛋白融合蛋白的克隆与表达
Avicenna J Med Biotechnol. 2016 Oct-Dec;8(4):175-181.
4
Overview of the purification of recombinant proteins.重组蛋白纯化概述。
Curr Protoc Protein Sci. 2015 Apr 1;80:6.1.1-6.1.35. doi: 10.1002/0471140864.ps0601s80.
5
P2' benzene carboxylic acid moiety is associated with decrease in cellular uptake: evaluation of novel nonpeptidic HIV-1 protease inhibitors containing P2 bis-tetrahydrofuran moiety.P2' 苯羧酸部分与细胞摄取减少相关:含 P2 双四氢呋喃部分的新型非肽类 HIV-1 蛋白酶抑制剂的评估。
Antimicrob Agents Chemother. 2013 Oct;57(10):4920-7. doi: 10.1128/AAC.00868-13. Epub 2013 Jul 22.
6
Optimizing HIV-1 protease production in Escherichia coli as fusion protein.优化 HIV-1 蛋白酶在大肠杆菌中的融合蛋白表达。
Microb Cell Fact. 2011 Jun 30;10:53. doi: 10.1186/1475-2859-10-53.
7
An Escherichia coli expression assay and screen for human immunodeficiency virus protease variants with decreased susceptibility to indinavir.一种用于检测和筛选对茚地那韦敏感性降低的人类免疫缺陷病毒蛋白酶变体的大肠杆菌表达分析方法。
Antimicrob Agents Chemother. 1998 Dec;42(12):3256-65. doi: 10.1128/AAC.42.12.3256.
8
Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease.影响人类免疫缺陷病毒1型p15NC与RNA相互作用及病毒蛋白酶增强切割作用的决定因素。
J Virol. 1997 Aug;71(8):5723-32. doi: 10.1128/JVI.71.8.5723-5732.1997.
9
Efficient production of Thermus protease aqualysin I in Escherichia coli: effects of cloned gene structure and two-stage culture.嗜热栖热菌蛋白酶水解素I在大肠杆菌中的高效生产:克隆基因结构和两阶段培养的影响
Appl Microbiol Biotechnol. 1996 Mar;45(1-2):94-101. doi: 10.1007/s002530050654.
10
Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance spectroscopy.通过核磁共振光谱法测定的与新型环状脲类抑制剂DMP323复合的HIV-1蛋白酶的三维溶液结构。
Protein Sci. 1996 Mar;5(3):495-506. doi: 10.1002/pro.5560050311.